-
Je něco špatně v tomto záznamu ?
EAHP European Statements Survey 2018, focusing on Section 1: Introductory Statements and Governance, Section 3: Production and Compounding, and Section 4: Clinical Pharmacy Services
S. Amann, J. Underhill, P. Horák, A. Batista, N. Miljkovic, N. Gibbons
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
NLK
PubMed Central
od 2016
Europe PubMed Central
od 2016 do Před 1 rokem
ProQuest Central
od 2012-02-01 do Před 6 měsíci
Health & Medicine (ProQuest)
od 2012-02-01 do Před 6 měsíci
- MeSH
- farmaceuti MeSH
- farmacie * MeSH
- lékárny * MeSH
- lidé MeSH
- nemocniční lékárny * MeSH
- průzkumy a dotazníky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: The 2018 EAHP European Statements Survey focused on sections 1, 3 and 4 of the European Statements of Hospital Pharmacy. Statistical data on the level of implementation and on the main barriers to implementation of the Statements were collected. A further aim was to identify barriers in general, such as lack of awareness. METHODS: An online questionnaire was sent to all hospital pharmacies in EAHP member countries. Data were analysed at Keele University School of Pharmacy, UK. As with previous reports, the survey was divided into three sections: section A, asking general questions about the hospital pharmacy; Section B, addressing questions about the current activity of pharmacists around each statement from Sections 1, 3 and 4; and Section C, focusing on their ability to implement the statements. RESULTS: 719 complete responses were obtained from a sample of 5164 hospital pharmacies, giving a response rate of 14% (719/5164). Section A results indicated that 45% (323/719) of responders worked in teaching hospitals, 79% (568/719) of hospital pharmacies had 10 or fewer pharmacists, and 48% (345/719) of hospital pharmacies served over 500 beds. Section B results found a high percentage of positive responses for activity in section 1 (introductory statements and governance) and section 3 (production and compounding). However, responses to questions in section 4 (clinical pharmacy services) were more variable, with 6 of the 15 questions being answered positively by less than half of respondents. The five questions that revealed the lowest implementation levels were then analysed in greater detail. These questions corresponded to Statements 4.4, 4.5, 4.8, 1.1, and 4.2, which need the greatest effort for implementation. The major identified barriers to implementation were 'lack of capacity' and that 'other health professionals in the hospital fulfil the tasks'. CONCLUSIONS: This survey provides useful information on the implementation status (and the barriers to, and drivers of implementation) of sections 1, 3 and 4 of the Statements. This will allow the EAHP to plan its implementation support programme for its members. To increase the quality of data, as well as the feedback to hospital pharmacies, the EAHP is planning to combine the survey with the self-assessment tool of the European Statements of Hospital Pharmacy.
Centre for Medicines Optimisation Keele University Keele Staffs UK
Hospital Pharmacy Institute for orthopaedic surgery Banjica Beograd Serbia
Hospital Pharmacy Motol University Hospital Praha Praha Czech Republic
hospitalar 5 N de Gaia Portugal
Keele University Centre for Medicines Optimisation Keele University Keele Staffordshire UK
Krankenhausapotheke Stadtisches Klinikum Munchen GmbH Munchen Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22019521
- 003
- CZ-PrNML
- 005
- 20220804135730.0
- 007
- ta
- 008
- 220720s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/ejhpharm-2019-002028 $2 doi
- 035 __
- $a (PubMed)34930791
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Amann, Steffen $u Krankenhausapotheke (Hospital Pharmacy), Stadtisches Klinikum Munchen GmbH, Munchen, Germany amann@adka.de
- 245 10
- $a EAHP European Statements Survey 2018, focusing on Section 1: Introductory Statements and Governance, Section 3: Production and Compounding, and Section 4: Clinical Pharmacy Services / $c S. Amann, J. Underhill, P. Horák, A. Batista, N. Miljkovic, N. Gibbons
- 520 9_
- $a OBJECTIVES: The 2018 EAHP European Statements Survey focused on sections 1, 3 and 4 of the European Statements of Hospital Pharmacy. Statistical data on the level of implementation and on the main barriers to implementation of the Statements were collected. A further aim was to identify barriers in general, such as lack of awareness. METHODS: An online questionnaire was sent to all hospital pharmacies in EAHP member countries. Data were analysed at Keele University School of Pharmacy, UK. As with previous reports, the survey was divided into three sections: section A, asking general questions about the hospital pharmacy; Section B, addressing questions about the current activity of pharmacists around each statement from Sections 1, 3 and 4; and Section C, focusing on their ability to implement the statements. RESULTS: 719 complete responses were obtained from a sample of 5164 hospital pharmacies, giving a response rate of 14% (719/5164). Section A results indicated that 45% (323/719) of responders worked in teaching hospitals, 79% (568/719) of hospital pharmacies had 10 or fewer pharmacists, and 48% (345/719) of hospital pharmacies served over 500 beds. Section B results found a high percentage of positive responses for activity in section 1 (introductory statements and governance) and section 3 (production and compounding). However, responses to questions in section 4 (clinical pharmacy services) were more variable, with 6 of the 15 questions being answered positively by less than half of respondents. The five questions that revealed the lowest implementation levels were then analysed in greater detail. These questions corresponded to Statements 4.4, 4.5, 4.8, 1.1, and 4.2, which need the greatest effort for implementation. The major identified barriers to implementation were 'lack of capacity' and that 'other health professionals in the hospital fulfil the tasks'. CONCLUSIONS: This survey provides useful information on the implementation status (and the barriers to, and drivers of implementation) of sections 1, 3 and 4 of the Statements. This will allow the EAHP to plan its implementation support programme for its members. To increase the quality of data, as well as the feedback to hospital pharmacies, the EAHP is planning to combine the survey with the self-assessment tool of the European Statements of Hospital Pharmacy.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a lékárny $7 D010594
- 650 _2
- $a farmaceuti $7 D010595
- 650 12
- $a farmacie $7 D010604
- 650 12
- $a nemocniční lékárny $7 D010607
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Underhill, Jonathan $u Keele University Centre for Medicines Optimisation, Keele University, Keele, Staffordshire, UK
- 700 1_
- $a Horák, Petr $u Hospital Pharmacy, Motol University Hospital, Praha, Praha, Czech Republic
- 700 1_
- $a Batista, Aida $u hospitalar, V.N. de Gaia, Portugal
- 700 1_
- $a Miljkovic, Nenad $u Hospital Pharmacy, Institute for orthopaedic surgery Banjica, Beograd, Serbia
- 700 1_
- $a Gibbons, Nicholas $u Centre for Medicines Optimisation, Keele University, Keele, Staffs, UK
- 773 0_
- $w MED00200143 $t European journal of hospital pharmacy : science and practice $x 2047-9956 $g Roč. 29, č. 1 (2022), s. 26-32
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34930791 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804135723 $b ABA008
- 999 __
- $a ok $b bmc $g 1822923 $s 1170764
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 29 $c 1 $d 26-32 $e 20191202 $i 2047-9956 $m European journal of hospital pharmacy $n Eur J Hosp Pharm $x MED00200143
- LZP __
- $a Pubmed-20220720